Michigan Initial Experience Using Tigertriever for Thrombectomy

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Henry Ford Health System
Study ID
NCT07363525
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Mechanical Thrombectomy — PROCEDURE
    You will be asked to provide medical history, take neurological exams in the form of questionnaires, and provide imaging data.

Study Details

The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.

Key Dates

Start date
Jan 15, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Thrombectomy Treated Patients
    Patients are enrolled only if the use of the Tigertreiver is used during surgery.

Primary Outcome Measure

Modified Rankin Scale [ Time Frame: From enrollment to 90 days post treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Henry Ford HospitalDetroitMichigan48202
Alex B Chebl, MD
[email protected]
3132070432
Kelly Tundo
[email protected]

Find similar trials in Detroit, MI

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
Henry Ford Hospital· Detroit, MI

Related Studies